Medicine information
Uses & overview
TRELAQWK 50, from Steris Healthcare, is an oral antidiabetic formulation containing Trelagliptin 50 mg. Trelagliptin belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class, which helps support blood glucose regulation in adults with type 2 diabetes mellitus. Composition Each tablet contains: Trelagliptin: 50 mg Company Name: Steris Healthcare Key Product Features Contains Trelagliptin 50 mg. Belongs to the DPP-4 inhibitor class of antidiabetic medicines. Supports glucose regulation through incretin-related mechanisms. Intended for use under medical supervision as part of an individualized diabetes management plan. Uses of TRELAQWK 50 Trelagliptin is used for blood glucose management in adults with type 2 diabetes mellitus in countries where it is approved. The suitability of TRELAQWK 50 depends on local regulatory approval, the patient's medical condition, and the prescribing healthcare professional's assessment. How TRELAQWK 50 Works Trelagliptin inhibits the DPP-4 enzyme, which normally breaks down incretin hormones. By prolonging incretin activity, it helps support glucose-dependent insulin release and reduces glucagon secretion when blood glucose levels are elevated. This action helps regulate blood glucose levels. Important Safety Information TRELAQWK 50 should be used only under the supervision of a qualified healthcare professional and in accordance with the approved product information. Possible adverse effects associated with DPP-4 inhibitors include gastrointestinal symptoms, headache, and hypersensitivity reactions. Severe or persistent abdominal pain should be assessed promptly because pancreatitis has been reported with medicines in this class. Low blood sugar may occur when used with other antidiabetic medicines, particularly sulfonylureas or insulin. Inform your doctor if you have kidney problems, a history of pancreatitis, or any known allergies to medicines. The appropriate dose and suitability of treatment depend on the patient's clinical condition and applicable prescribing guidance. Disclaimer: This information is for educational purposes only and does not replace professional medical advice or the approved prescribing information. About Steris Healthcare TRELAQWK 50 is a brand associated with Steris Healthcare. For verified company information, product availability, and business or distribution enquiries, refer to the official company details.
How to use
Take TRELAQWK 50 only as directed by your doctor and follow the approved product instructions. Do not change the dose, frequency, or duration of treatment without medical advice. Inform your healthcare professional about other medicines you take and any existing medical conditions, particularly kidney problems. Follow your recommended diet, physical activity plan, and blood glucose monitoring schedule.
